233 related articles for article (PubMed ID: 29760049)
1. Insulin suppresses the production of fibroblast growth factor 23 (FGF23).
Bär L; Feger M; Fajol A; Klotz LO; Zeng S; Lang F; Hocher B; Föller M
Proc Natl Acad Sci U S A; 2018 May; 115(22):5804-5809. PubMed ID: 29760049
[TBL] [Abstract][Full Text] [Related]
2. 1ɑ,25-Dihydroxyvitamin D
Luo W; Jiang Y; Yi Z; Wu Y; Gong P; Xiong Y
J Cell Mol Med; 2021 Apr; 25(8):4148-4156. PubMed ID: 33609082
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated kinase is a regulator of fibroblast growth factor 23 production.
Glosse P; Feger M; Mutig K; Chen H; Hirche F; Hasan AA; Gaballa MMS; Hocher B; Lang F; Föller M
Kidney Int; 2018 Sep; 94(3):491-501. PubMed ID: 29861059
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
[TBL] [Abstract][Full Text] [Related]
5. A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFα upregulation.
Glosse P; Fajol A; Hirche F; Feger M; Voelkl J; Lang F; Stangl GI; Föller M
Nutr Diabetes; 2018 May; 8(1):36. PubMed ID: 29807981
[TBL] [Abstract][Full Text] [Related]
6. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
[TBL] [Abstract][Full Text] [Related]
7. Enhanced FGF23 production in mice expressing PI3K-insensitive GSK3 is normalized by β-blocker treatment.
Fajol A; Chen H; Umbach AT; Quarles LD; Lang F; Föller M
FASEB J; 2016 Feb; 30(2):994-1001. PubMed ID: 26527066
[TBL] [Abstract][Full Text] [Related]
8. Insulin and insulin-like growth factor-1 can modulate the phosphoinositide-3-kinase/Akt/FoxO1 pathway in SZ95 sebocytes in vitro.
Mirdamadi Y; Thielitz A; Wiede A; Goihl A; Papakonstantinou E; Hartig R; Zouboulis CC; Reinhold D; Simeoni L; Bommhardt U; Quist S; Gollnick H
Mol Cell Endocrinol; 2015 Nov; 415():32-44. PubMed ID: 26257240
[TBL] [Abstract][Full Text] [Related]
9. p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes.
Ewendt F; Föller M
J Endocrinol Invest; 2019 Dec; 42(12):1477-1483. PubMed ID: 31201665
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.
Daryadel A; Bettoni C; Haider T; Imenez Silva PH; Schnitzbauer U; Pastor-Arroyo EM; Wenger RH; Gassmann M; Wagner CA
Pflugers Arch; 2018 Oct; 470(10):1569-1582. PubMed ID: 29961920
[TBL] [Abstract][Full Text] [Related]
11. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis.
Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG
J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.
Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M
FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153
[TBL] [Abstract][Full Text] [Related]
13. New insights into the FGF23-Klotho axis.
Olauson H; Vervloet MG; Cozzolino M; Massy ZA; Ureña Torres P; Larsson TE
Semin Nephrol; 2014 Nov; 34(6):586-97. PubMed ID: 25498378
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
Prié D; Friedlander G
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
[TBL] [Abstract][Full Text] [Related]
16. FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice.
Du E; Xiao L; Hurley MM
J Cell Physiol; 2017 Mar; 232(3):610-616. PubMed ID: 27306296
[TBL] [Abstract][Full Text] [Related]
17. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and type II sodium-dependent phosphate cotransporters.
Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
[TBL] [Abstract][Full Text] [Related]
19. Regulation of fibroblast growth factor 23 (FGF23) in health and disease.
Bär L; Stournaras C; Lang F; Föller M
FEBS Lett; 2019 Aug; 593(15):1879-1900. PubMed ID: 31199502
[TBL] [Abstract][Full Text] [Related]
20. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
Kuro-o M
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
